Skip to content

CDR

New kind of chairman coming to NACDS

Come April, the National Association of Chain Drug Stores will put in place the first chairman in its 78-year history who has not come from the chain drug store industry. The NACDS chairman-in-waiting is Bob Loeffler. He is primarily a food retailer, having spent his retailing career with H.E.

Bayer Consumer Care names president

Former Pfizer executive Erica Mann is set to join Bayer HealthCare LLC as the new president of its Consumer Care Division. Plans call for Mann, most recently president and general manager of Pfizer Nutritional Health, to start at Bayer on March 14.

American Greetings gives online peek at what’s new in stores

American Greetings Corp. has enabled consumers to shop for electronic greeting cards on its web site for quite some time, and now they also can go online to find out what’s new in the card aisle at stores. The greeting card company said this week it has launched a new page on AmericanGreetings.com

Forest Labs to acquire Clinical Data

Forest Laboratories Inc. plans to buy specialty pharmaceutical firm Clinical Data Inc. in a deal valued at $1.2 billion. The companies said Tuesday that under the agreement, Forest will acquire Clinical Data for $30 per share in cash plus up to $6 per share upon achievement of certain commercial

Florida’s governor urged not to nix Rx monitoring program

A group of congressmen have called on Florida’s governor not to scrap plans for a prescription drug monitoring program, citing the prevalence of illegal trafficking of prescription narcotics from the state. Sens. Joe Manchin (D., W.Va.), Charles Schumer (D., N.Y.), Bill Nelson (D., Fla.

NCPDP webinar offers pharmacists REMS primer

The National Council for Prescription Drug Programs (NCPDP) this week is holding a webinar on Risk Evaluation and Mitigation Strategies (REMS) that gives pharmacies and pharmaceutical manufacturers solutions to optimize patient care.

GPhA sets 2011 executive committee, board

The Generic Pharmaceutical Association (GPhA) has elected members of its 2011 executive committee and board of directors. GPhA said late last week that Paul Bisaro, president and chief executive officer of Watson Pharmaceuticals Inc., has been re-elected as chairman for a second one-year term.